Dermatologic reactions to targeted therapy: A focus on epidermal growth factor receptor inhibitors and nursing care Journal Article


Authors: Barton-Burke, M.; Ciccolini, K.; Mekas, M.; Burke, S.
Article Title: Dermatologic reactions to targeted therapy: A focus on epidermal growth factor receptor inhibitors and nursing care
Abstract: Cancer treatments usually have side effects of bone marrow depression, mucositis, hair loss, and gastrointestinal issues. Rarely do we think of skin side effects until patients have been treated successfully with epidermal growth factor receptor inhibitors (EGFRi). Those reactions include papulopustular rash, hair changes, radiation dermatitis enhancement, pruritus, mucositis, xerosis, fissures, and paronychia. This article discusses the common skin reactions seen when using EGFRi and presents an overview of skin as the largest and important organ of the body, including an overview of skin assessment, pathophysiology of the skin reactions, nursing care involved, and introduction to oncodermatology. © 2016 Elsevier Inc.
Keywords: skin reactions; egfri (epidermal growth factor receptor inhibitors); oncodermatology
Journal Title: Nursing Clinics of North America
Volume: 52
Issue: 1
ISSN: 0029-6465
Publisher: W.B. Saunders Co.  
Date Published: 2017-03-01
Start Page: 83
End Page: 113
Language: English
DOI: 10.1016/j.cnur.2016.11.005
PROVIDER: scopus
PUBMED: 28189168
PMCID: PMC5645079
DOI/URL:
Notes: Chapter in "Advances in Oncology Nursing" (ISBN: 9780323530170) -- Review -- Export Date: 2 March 2017 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Maria Christina Mekas
    2 Mekas
  2. Sean Burke
    1 Burke